Navigation Links
TorkLaw Continuing to Accept DePuy ASR Hip Implant Cases - Deadline Approaching January 6, 2014
Date:12/27/2013

LOS ANGELES, Dec. 27, 2013 /PRNewswire/ -- In November 2013, Johnson & Johnson announced that it has agreed to pay at least $2.5 billion to settle nearly 8,000 DePuy Orthopaedics Hip Implant lawsuits which have been filed across the country.  It is estimated by some accounts that the total settlement figure could reach $4 billion.

The settlement will focus on cases stemming from injuries caused to patients by the recalled DePuy ASR hip system.  The more than 8,000 potential injured victims had to have had revision or corrective surgery prior to August 31, 2013. 

The deadline to register a claim to be a part of this settlement is January 6, 2014.

"We are urging victims of the DePuy hip system to contact us as soon as possible to determine if they are eligible to be a part of the settlement," said Reza Torkzadeh, Founder of The Torkzadeh Law Firm.

The settlement will be handled in two phases.  Victims must first register before the deadline.  They then have until April 1, 2014 to "opt-in."  Once a victim has become a part of the settlement, a baseline value of $250,000.00 per claimant has been set aside.  From there, each claimant will be evaluated independently based on injuries, medical bills, history and other various damages that each victim has suffered.  Additional compensation may then be awarded.

"There are over 12,000 lawsuits filed across the country against Johnson & Johnson for the defective DePuy hip implant.  These metal-on-metal devices are very dangerous and have caused some serious and permanent injuries to victims across the country.  This settlement will help some, but not all of the victims who have been impacted by DePuy.  We intend on litigating cases on behalf of those who are not compensated under this settlement," said Torkzadeh.

If you have been injured by the DePuy ASR hip implant, please call immediately to be a part of the $2.5 billion settlement.  Call now for a free consultation 888.222.8286. For more information, visit our DePuy Lawsuit information page.

CONTACT: The Torkzadeh Law Firm, 310-935-1111


'/>"/>
SOURCE The Torkzadeh Law Firm
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TorkLaw Accepting St. Jude Medical Device Cases
2. TorkLaw Accepting DePuy Hip Implant Cases
3. TorkLaw Responds to FDA Warning Letter to St. Jude Medical Regarding Defective Heart Device; Now Representing Patients in 15 States
4. Herborium Announces Continuing Progress In Key Strategic Initiatives
5. China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012
6. EPIC Pharmacies offers members discounted access to online continuing education course - Management & HR Skills for Pharmacists
7. New Research Shows Continuing Medical Education Saves Healthcare Costs
8. MSA Announces Record Continuing Sales and Operating Income
9. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
10. Attention Veterans: New Medtech Job Training Program Accepting Applications through Friday, August 31
11. Pennsylvania State Police to Accept Expired, Unwanted Prescription Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release of ... in Cannes (France), XO Private has initiated a second print-run of its lavish luxury ... a metre across when open, weighs in at more than six kilos, retails at ...
(Date:2/24/2017)... ... , ... An in-depth computational analysis of genetic variants implicated in both schizophrenia ... that may explain why susceptibility to one of the disorders could place individuals at ... in the journal npj Schizophrenia. , “There is a wealth of genomic data ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only could it ... the United States may be taken over by technology in the next five to ... over colleagues is drawing to a close. Success will belong to those who can ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ... is so critically important that we all are aware of our options and ... is proud to announce the launch of its newest edition of "Vision and ...
Breaking Medicine News(10 mins):